Human Primary Cells Market By Type ( Epithelial Cells, Fibroblasts, Hematopoietic, Liver Cells, Mesenchymal Stem Cells, Pericytes ), By Application ( Medical, Scientific Research ), Estimation & Forecast, 2017 - 2022

Check Today's Best Price

$3500 Buy Now
Human Primary Cells Market is expected to grow with a CAGR of 8.8% during the forecast period of 2017 to 2022.
  • Human primary cells are the cells isolated directly from human tissue via enzymatic or mechanical method. Primary cells provide unaltered and natural experimental results, as they are physiologically normal. Normal primary cells retain almost all native cellular functions in vitro, such as morphology, cellular function, growth characteristics, cellular markers, signaling and genetic integrity. This results into higher quality research data and subsequently leads to a better understanding of complex cellular processes in the development of efficacious therapies to improve or cure human disease. As the primary cells maintain their fundamental cellular functions, integrating them into cell-based research programs has the potential to deliver biologically relevant and meaningful data. The use of primary cells has become more commonplace and in certain cases has been mandated to receive data approval or further research funding. Such a trend is reflective of the push to incorporate more reliable cell culture tools into research and the emergence of high quality normal primary cells is at the forefront of such efforts. The prevalent availability of high quality primary cells and support reagents has paved the way for new avenues of cell-based and cell biology research. Improvements in cell isolation and cryopreservation procedures, optimized media and reagents, and streamlined use of protocols have allowed researchers to readily integrate robust primary cell systems into a wide variety of research programs. Moreover, the commercial primary cell providers are bridging up the gap to enable scientists to leverage their time and resources to focus on their own research and development.

    HUMAN PRIMARY CELLS MARKET DETERMINANTS-IMPACT ANALYSIS, 2017 Vs. 2022

    Human Primary Cells Market

    Market Determinants

    The advent of newer technologies such as 3D culture, the use of primary cells are becoming increasingly prevalent to achieve improved results. The rapid growth in biotechnology and biopharmaceutical industries is slated to be the major driving force for the growth of human primary cell market. The Increasing research on personalized therapies and stem cells is fueling the growth of the market. Moreover, surge in the number of organ transplants and biobanking of cells, tissues and organs is driving growth of the market.

    ASIA PACIFIC HUMAN PRIMARY CELLS MARKET BY TYPE, (2017-2022)

    Human Primary Cells Market

    Human Primary Cells Market Segmentation

    By Type
    • Epithelial Cells
    • Fibroblasts
    • Hematopoietic
    • Liver Cells
    • Mesenchymal Stem Cells
    • Muscle Cells
    • Pericytes

    By Application
    • Medical Research
    • Clinical Research
    • Other

    By Geography
    • North America
    • Europe
    • China
    • Japan
    • South-East Asia
    • India

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. HUMAN PRIMARY CELLS MARKET OVERVIEW
    2.1. PRODUCT OVERVIEW
    2.2. HUMAN PRIMARY CELLS SEGMENT BY TYPE (PRODUCT CATEGORY)
    2.2.1. Global Human Primary Cells Production and CAGR (%) Comparison by Type (Product Category)(2017-2025)
    2.2.2. Global Human Primary Cells Production Market Share by Type (Product Category) in 2017
    2.2.3. Epithelial Cells
    2.2.4. Fibroblasts
    2.2.5. Hematopoietic
    2.2.6. Liver Cells
    2.2.7. Mesenchymal Stem Cells
    2.2.8. Muscle Cells
    2.2.9. Pericytes
    2.3. GLOBAL HUMAN PRIMARY CELLS SEGMENT BY APPLICATION
    2.3.1. Human Primary Cells Consumption (Sales) Comparison by Application (2017-2025)
    2.3.2. Medical Research
    2.3.3. Clinical Research
    2.4. GLOBAL HUMAN PRIMARY CELLS MARKET BY REGION (2017-2025)
    2.4.1. Global Human Primary Cells Market by region (2017-2025)
    2.4.2. U.S. Status and Prospect (2017-2025)
    2.4.3. Europe Status and Prospect (2017-2025)
    2.4.4. China Status and Prospect (2017-2025)
    2.4.5. Japan Status and Prospect (2017-2025)
    2.4.6. Southeast Asia Status and Prospect (2017-2025)
    2.4.7. India Status and Prospect (2017-2025)
    2.5. GLOBAL HUMAN PRIMARY CELLS (2017-2025), PRODUCTION AND CAPACITY ANALYSIS
    2.5.1. Production and capacity comparison by region (2017-2025)

    CHAPTER 3. GLOBAL HUMAN PRIMARY CELLS MARKET PLAYER ANALYSIS
    3.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY MANUFACTURERS (2016-2017)
    3.1. GLOBAL HUMAN PRIMARY CELLS RVENUE AND MARKET SHARE BY MANUFACTURERS (2016-2017)
    3.1. GLOBAL HUMAN PRIMARY CELLS TOP FIVE MANUFACTURERS MARKET SHARE (2016-2017)

    CHAPTER 4. GLOBAL HUMAN PRIMARY CELLS PRODUCTION (VOLUME), REVENUE (VALUE) BY REGION (2017-2025)
    4.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY REGION (2017-2025)
    4.2. GLOBAL HUMAN PRIMARY CELLS REVENUE (VALUE) AND MARKET SHARE BY REGION (2017-2025)
    4.3. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    4.4. U.S. HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    4.5. EUROPE HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    4.6. CHINA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    4.7. JAPAN HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    4.8. SOUTHEAST ASIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    4.9. INDIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)

    CHAPTER 5. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY REGION (2017-2025)
    5.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY REGION (2017-2025)
    5.2. U.S. HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    5.3. EUROPE HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    5.4. CHINA HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    5.5. JAPAN HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    5.6. SOUTHEAST ASIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    5.7. INDIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025)

    CHAPTER 6. GLOBAL HUMAN PRIMARY CELLS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
    6.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY TYPE (2017-2025)
    6.2. GLOBAL HUMAN PRIMARY CELLS REVENUE AND MARKET SHARE BY TYPE (2017-2025)
    6.3. GLOBAL HUMAN PRIMARY CELLS PRODUCTION GROWTH BY TYPE (2017-2025)

    CHAPTER 7. GLOBAL HUMAN PRIMARY CELLS MARKET ANALYSIS BY APPLICATION
    7.1. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION AND MARKET SHARE BY APPLICATION (2017-2025)
    7.2. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION GROWTH RATE BY APPLICATION (2017-2025)
    7.3. MARKET DRIVERS
    7.3.1. Potential Applications

    CHAPTER 8. GLOBAL HUMAN PRIMARY CELLS MANUFACTURERS PROFILES/ANALYSIS
    8.1. LONZA
    8.1.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.1.2. Human Primary Cells Product Category, Application and Specification
    8.1.2.1. Clonetics™ Normal Human Articular Chondrocytes (NHAC-kn)
    8.1.2.2. Hepatocytes & Media
    8.1.2.2.1. Fresh Human Hepatocytes
    8.1.2.2.2. Cryopreserved Human Hepatocytes
    8.1.3. Lonza Human Primary Cells Capacity, Production, Revenue, Price and Gross Margin (2017-2025)
    8.1.4. Main Business/Business OverviewCompany Profile
    8.2. THERMO FISHER SCIENTIFIC
    8.2.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.2.2. Human Primary Cells Product Category, Application and Specification
    8.2.2.1. Human Mammary Epithelial Cells (HMEC)
    8.2.2.2. Human Umbilical Vein Endothelial Cells (HUVEC )
    8.2.3. Thermo Fisher Scientific Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025)
    8.2.4. Main Business/Business Overview
    8.3. SIGMA-ALDRICH
    8.3.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.3.2. Human Primary Cells Product Category, Application and Specification
    8.3.2.1. MTOXH1002 (Cryoplateable Primary Human Hepatocytes)
    8.3.2.2. MTOXH1012 (Cryopreserved Primary Human Hepatocytes Juvenile)
    8.3.3. Sigma-Aldrich Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025)
    8.3.4. Main Business/Business Overview
    8.4. CELL BIOLOGICS
    8.4.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.4.2. Human Primary Cells Product Category, Application and Specification
    8.4.2.1. HUMAN PRIMARY AORTIC ENDOTHELIAL CELLS
    8.4.2.2. HUMAN PRIMARY AORTIC FIBROBLASTS
    8.4.3. Main Business/Business Overview
    8.5. PROMOCELL GMBH
    8.5.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.5.2. Human Primary Cells Product Category, Application and Specification
    8.5.2.1. Melanocytes
    8.5.2.2. Cardiac Myocytes
    8.5.3. Main Business/Business Overview
    8.6. CURELINE
    8.6.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.6.2. Human Primary Cells Product Category, Application and Specification
    8.6.2.1. Spleen Primary Cell Line
    8.6.3. Cureline Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025)
    8.6.4. Main Business/Business Overview
    8.7. ZEN-BIO
    8.7.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.7.2. Human Primary Cells Product Category, Application and Specification
    8.7.2.1. Human Adult Melanocytes
    8.7.2.2. Adult Stem Cells
    8.7.3. Main Business/Business Overview
    8.8. STEMCELL TECHNOLOGIES
    8.8.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.8.2. Human Primary Cells Product Category, Application and Specification
    8.8.2.1. Human Peripheral Blood Monocytes
    8.8.2.2. Human Platelet Lysate, Fibrinogen-Depleted
    8.8.3. STEMCELL Technologies Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025)
    8.8.4. Main Business/Business Overview
    8.9. CELL APPLICATIONS
    8.9.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.9.2. Human Primary Cells Product Category, Application and Specification
    8.9.2.1. Human Hair Follicle Dermal Papilla Cells
    8.9.2.2. Chondrocyte
    8.9.3. Main Business/Business Overview
    8.10. PELOBIOTECH
    8.10.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors
    8.10.2. Human Primary Cells Product Category, Application and Specification
    8.10.2.1. Human Basal Cell Carcinoma Primary Cell Culture – Frozen Vial
    8.10.2.2. Human Brain Endothelial Primary Cell Culture Serum Free Media
    8.10.3. Main Business/Business Overview
    8.11. CREATIVE BIOARRAY
    8.11.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors
    8.11.2. Human Primary Cells Product Category, Application And Specification
    8.11.2.1. Human Synovial Membrane Fibroblasts
    8.11.2.2. Human Leptomeningeal Pericytes
    8.11.3. Business Overview
    8.12. CHARLES RIVER LABORATORIES
    8.12.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors
    8.12.2. Charles River Laboratories HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    8.12.3. Business Overview
    8.13. AXOL BIOSCIENCE
    8.13.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors
    8.13.2. Human Primary Cells Product Category, Application And Specification
    8.13.2.1. PRIMARY ENDOTHELIAL CELLS
    8.13.2.2. DENTAL PULP STEM CELLS
    8.13.3. Business Overview
    8.14. REACHBIO RESEARCH LABS
    8.14.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors
    8.14.2. Human Primary Cells Product Category, Application And Specification
    8.14.2.1. Human Peripheral Blood Mononuclear Cells (PBMCs) – Light Density
    8.14.2.2. Human Cord Blood MNCs
    8.14.3. Business Overview

    CHAPTER 9. HUMAN PRIMARY CELLS VALUE CHAIN ANALYSIS
    9.1. HUMAN PRIMARY CELLS KEY RAW MATERIALS ANALYSIS
    9.1.1. Bargaining power of suppliers
    9.1.2. Key Suppliers of Raw Materials
    9.2. MANUFACTURING PROCESS ANALYSIS OF HUMAN PRIMARY CELLS

    CHAPTER 10. INDUSTRIAL CHAIN, SOURCING STRATEGY
    10.2. HUMAN PRIMARY CELLS MAJOR MANUFACTURERS IN 2017
    10.3. CUSTOMER ANALYSIS

    CHAPTER 11. MARKET ENTRY & SALES STRATEGY
    11.1. ENTRY STRATEGY
    11.2. SALES AND MARKETING
    11.3. PRICING STRATEGY

    CHAPTER 12. GLOBAL HUMAN PRIMARY CELLS MARKET HISTORICAL DATA (2014-2016)
    12.1. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE HISTORICAL DATA (2014-2016)
    12.1.1. Global Human Primary Cells Capacity, Production and Growth Rate (2014-2016)
    12.1.2. Global Human Primary Cells Revenue and Growth Rate (2014-2016)
    12.1.3. Global Human Primary Cells Price and Trend (2014-2016)
    12.2. GLOBAL HUMAN PRIMARY CELLS PRODUCTION HISTORICAL DATA BY REGION (2014-2016)
    12.2.1. U.S. Human Primary Cells Production, Revenue (2014-2016)
    12.2.2. Europe Human Primary Cells Production, Revenue (2014-2016)
    12.2.3. China Human Primary Cells Production, Revenue (2014-2016)
    12.2.4. Japan Human Primary Cells Production, Revenue (2014-2016)
    12.2.5. Southeast Asia Human Primary Cells Production, Revenue (2014-2016)
    12.2.6. India Human Primary Cells Production, Revenue, Consumption (2014-2016)

    LIST OF TABLES

    TABLE NO 1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND CAGR (%) COMPARISON BY TYPE (PRODUCT CATEGORY)(2017-2025)
    TABLE NO 2. HUMAN PRIMARY CELLS CONSUMPTION (MILLION UNITS) COMPARISON BY APPLICATION (2017-2025)
    TABLE NO 3. GLOBAL HUMAN PRIMARY CELLS MARKET SIZE (VALUE) AND CAGR (%) COMPARISON BY REGION (2017-2025)
    TABLE NO 4. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    TABLE NO 5. GLOBAL HUMAN PRIMARY CELLS REVENUE ($ MILLION) AND SHARE BY MANUFACTURERS (2017-2025)
    TABLE NO 6. GLOBAL HUMAN PRIMARY CELLS AVERAGE PRICE BY MANUFACTURERS (2017-2025)
    TABLE NO 7. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY REGION (2017-2025)
    TABLE NO 8. GLOBAL HUMAN PRIMARY CELLS REVENUE (VALUE) AND MARKET SHARE BY REGION (2017-2025)
    TABLE NO 9. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 10. U.S. HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 11. EUROPE HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 12. CHINA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 13. JAPAN HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 14. SOUTHEAST ASIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 15. INDIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025)
    TABLE NO 16. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY TYPE (2017-2025)
    TABLE NO 17. GLOBAL HUMAN PRIMARY CELLS REVENUE AND MARKET SHARE BY TYPE (2017-2025)
    TABLE NO 18. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION AND MARKET SHARE BY APPLICATION (2017-2025)
    TABLE NO 19. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    TABLE NO 20. LONZA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    TABLE NO 21. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    TABLE NO 22. THERMO FISHER SCIENTIFIC HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    TABLE NO 23. SIGMA-ALDRICH HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    TABLE NO 24. CURELINE HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    TABLE NO 25. STEMCELL TECHNOLOGIES HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    TABLE NO 26. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    TABLE NO 27. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    TABLE NO 28. CHARLES RIVER LABORATORIES HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025)
    TABLE NO 29. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    TABLE NO 30. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS
    TABLE NO 31. KEY SUPPLIERS OF RAW MATERIALS
    TABLE NO 32. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE FORECAST (2017-2024)
    TABLE NO 33. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION AND GROWTH RATE FORECAST (2017-2024)
    TABLE NO 34. U.S. HUMAN PRIMARY CELLS PRODUCTION, REVENUE, FORECAST (2017-2024)
    TABLE NO 35. EUROPE HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024)
    TABLE NO 36. CHINA HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024)
    TABLE NO 37. JAPAN HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024)
    TABLE NO 38. SOUTHEAST ASIA HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024)
    TABLE NO 39. INDIA HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024)

    LIST OF FIGURES

    FIGURE NO 1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION MARKET SHARE BY TYPE (PRODUCT CATEGORY) IN 2017
    FIGURE NO 2. PRODUCT PICTURE OF EPITHELIAL CELLS
    FIGURE NO 3. PRODUCT PICTURE OF FIBROBLASTS
    FIGURE NO 4. PRODUCT PICTURE OF HEMATOPOIETIC
    FIGURE NO 5. PRODUCT PICTURE OF LIVER CELLS
    FIGURE NO 6. PRODUCT PICTURE OF MESENCHYMAL STEM CELLS
    FIGURE NO 7. PRODUCT PICTURE OF MUSCLE CELLS
    FIGURE NO 8. PRODUCT PICTURE OF PERICYTES
    FIGURE NO 9. U.S. HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025)
    FIGURE NO 10. EUROPE HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025)
    FIGURE NO 11. CHINA HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025)
    FIGURE NO 12. JAPAN HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025)
    FIGURE NO 13. SOUTHEAST ASIA HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025)
    FIGURE NO 14. INDIA HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025)
    FIGURE NO 15. GLOBAL HUMAN PRIMARY CELLS REVENUE STATUS AND OUTLOOK (2017-2025)
    FIGURE NO 16. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION STATUS AND OUTLOOK (2017-2025)
    FIGURE NO 17. HUMAN PRIMARY CELLS MARKET SHARE OF TOP 3 MANUFACTURERS
    FIGURE NO 18. HUMAN PRIMARY CELLS MARKET SHARE OF TOP 5 MANUFACTURERS
    FIGURE NO 19. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY REGION (2017-2025)
    FIGURE NO 20. U.S. HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    FIGURE NO 21. EUROPE HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    FIGURE NO 22. CHINA HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    FIGURE NO 23. JAPAN HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    FIGURE NO 24. SOUTHEAST ASIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    FIGURE NO 25. INDIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025)
    FIGURE NO 26. GLOBAL HUMAN PRIMARY CELLS PRODUCTION GROWTH BY TYPE (2017-2025)
    FIGURE NO 27. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION GROWTH RATE BY APPLICATION (2017-2025)
    FIGURE NO 28. MANUFACTURING PROCESS ANALYSIS OF HUMAN PRIMARY CELLS
    FIGURE NO 29. HUMAN PRIMARY CELLS INDUSTRIAL CHAIN ANALYSIS
    FIGURE NO 30. GLOBAL HUMAN PRIMARY CELLS REVENUE AND GROWTH RATE FORECAST (2017-2024)
    FIGURE NO 31. GLOBAL HUMAN PRIMARY CELLS PRICE AND TREND FORECAST (2017-2024)
    FIGURE NO 32. GLOBAL HUMAN PRIMARY CELLS PRODUCTION FORECAST BY REGION (2017-2024)
    FIGURE NO 33. GLOBAL HUMAN PRIMARY CELLS PRODUCTION FORECAST BY TYPE (2017-2024)
    FIGURE NO 34. GLOBAL HUMAN PRIMARY CELLS REVENUE FORECAST BY TYPE (2017-2024)
    FIGURE NO 35. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION FORECAST BY APPLICATION (2017-2024)

    keyboard_arrow_up
  • • Lonza
    • Thermo Fisher Scientific
    • Sigma-Aldrich
    • Cell Biologics
    • PromoCell GmbH
    • Cureline
    • Zen-Bio
    • Stemcell Technologies
    • Pelobiotech

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Human Primary Cells Market in 2016 and the expected market size by 2024, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2016 – 2024)?
• Which are the leading companies in the Human Primary Cells Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS